Rapt Therapeutics Inc (NASDAQ:RAPT)

29.10
Delayed Data
As of 3:59pm ET
 -0.10 / -0.34%
Today’s Change
9.86
Today|||52-Week Range
40.74
-20.77%
Year-to-Date

Today’s Trading

Previous close29.20
Today’s open29.14
Day’s range28.14 - 30.17
Volume20,483
Average volume (3 months)340,292
Market cap$832.3M
Data as of 3:59pm ET, 08/16/2022

Growth & Valuation

Earnings growth (last year)-15.29%
Earnings growth (this year)-18.10%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.38%
P/E ratioNM
Price/Sales263.85
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
ALTAltimmune Inc+0.11+0.63%
AGENAgenus Inc-0.15-4.78%
STOKStoke Therapeutics I...-1.44-6.71%
MORMorphoSys AG-0.14-2.28%
Data as of 4:00pm ET, 08/16/2022

Financials

Next reporting dateDecember 14, 2022
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$3.8M
Annual profit (last year)-$69.2M
Net profit margin-1,814.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts